Hear a customer success story from ITM (Isotope Technologies Munich) a leading, global radiopharmaceutical biotech company that develops, produces, and supplies cutting-edge targeted radiotherapeutics and diagnostics for cancer treatments. During this webinar ITM explains their evaluation and implementation process of the Growth Direct® and how automation and rapid testing has improved their quality control processes, allowing for accurate-confident results and faster product release.
What is Covered:
Key production challenges short half-life, radiation hazards that impact assay performance, and the need for robust aseptic controls.
Immediate Impact of the Growth Direct®: automated, digitized microbial testing that reduces manual handling, improves safety, strengthens data integrity, and delivers faster time to result (TTR) through early microcolony detection.
Customer Insight: ITM’s evaluation and implementation journey.
Key Takeaways:
Understand the value of fully automated technologies and quality control workflows for radiopharmaceutical production and release.
Learn firsthand practical considerations from ITM’s experience.
Discover how Growth Direct® technology accelerates TTR and improves reliability from the customers' perspective.
If you have additional questions about automating rapid microbial detection and enumeration for your QC microbiology processes, visit Rapid Micro Biosystems or click on the Request Information button below to contact the supplier.
